Induced Pluripotent Stem Cells Market

Table of Content

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Definition
     2.2. Market Taxonomy

3. Induced Pluripotent Stem cells Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity Analysis

4. Market Background
     4.1. Parent Market Overview
     4.2. Induced Pluripotent Stem Cell Timeline
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Trends

5. Macroeconomic Assumptions

6. Global Economic Outlook
     6.1. Gross Domestic Product by Region & Country, 2006 – 2021
     6.2. Healthcare Indicators

7. Key Inclusions
     7.1. Usage Trend in Industry
     7.2. Active Researchers in Stem Cell Research
     7.3. Induced Pluripotent Stem Cell Therapy for Cardiovascular Disease
     7.4. In-Vivo Modelling for Neurological Disorder Using Induced Pluripotent Stem Cells
     7.5. Pipeline Assessment

8. North America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Regional Market Trends
     8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            8.3.1. U.S.
            8.3.2. Canada
     8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            8.5.1. Hepatocytes
            8.5.2. Fibroblasts
            8.5.3. Keratinocytes
            8.5.4. Neurons
            8.5.5. Others
     8.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            8.7.1. Drug Development
            8.7.2. Toxicity testing
            8.7.3. Regenerative Medicine
            8.7.4. Others
     8.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            8.9.1. Academic & Research Institutes
            8.9.2. Biotechnology companies
            8.9.3. Others
     8.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     8.11. Drivers and Restraints: Impact Analysis
     8.12. Market Attractiveness Analysis
            8.12.1. By Country
            8.12.2. By Cell Type
            8.12.3. By Application
            8.12.4. By End User
     8.13. Key Market Participants – Intensity Mapping
     8.14. Drivers and Restraints – Impact Analysis

9. Latin America Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Regional Market Trends
     9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            9.3.1. Argentina
            9.3.2. Brazil
            9.3.3. Mexico
            9.3.4. Rest of Latin America
     9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     9.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            9.5.1. Hepatocytes
            9.5.2. Fibroblasts
            9.5.3. Keratinocytes
            9.5.4. Neurons
            9.5.5. Others
     9.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            9.7.1. Drug Development
            9.7.2. Toxicity testing
            9.7.3. Regenerative Medicine
            9.7.4. Others
     9.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            9.9.1. Academic & Research Institutes
            9.9.2. Biotechnology companies
            9.9.3. Others
     9.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     9.11. Drivers and Restraints: Impact Analysis
     9.12. Market Attractiveness Analysis
            9.12.1. By Country
            9.12.2. By Cell Type
            9.12.3. By Application
            9.12.4. By End User
     9.13. Key Market Participants – Intensity Mapping
     9.14. Drivers and Restraints – Impact Analysis
     9.15. Key Mergers & Acquisitions

10. Europe Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     10.1. Introduction
     10.2. Regional Market Trends
     10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            10.3.1. Germany
            10.3.2. U.K.
            10.3.3. France
            10.3.4. Italy
            10.3.5. Spain
            10.3.6. Russia
            10.3.7. Rest of Europe
     10.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     10.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            10.5.1. Hepatocytes
            10.5.2. Fibroblasts
            10.5.3. Keratinocytes
            10.5.4. Neurons
            10.5.5. Others
     10.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            10.7.1. Drug Development
            10.7.2. Toxicity testing
            10.7.3. Regenerative Medicine
            10.7.4. Others
     10.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            10.9.1. Academic & Research Institutes
            10.9.2. Biotechnology companies
            10.9.3. Others
     10.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     10.11. Drivers and Restraints: Impact Analysis
     10.12.Market Attractiveness Analysis
            10.12.1. By Country
            10.12.2. By Cell Type
            10.12.3. By Application
            10.12.4. By End User
     10.13. Key Market Participants – Intensity Mapping
     10.14. Drivers and Restraints – Impact Analysis
     10.15. Key Mergers & Acquisitions

11. Asia Pacific Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     11.1. Introduction
     11.2. Regional Market Trends
     11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            11.3.1. Japan
            11.3.2. India
            11.3.3. Australia and New Zealand
            11.3.4. Rest of Asia Pacific
     11.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     11.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            11.5.1. Hepatocytes
            11.5.2. Fibroblasts
            11.5.3. Keratinocytes
            11.5.4. Neurons
            11.5.5. Others
     11.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            11.7.1. Drug Development
            11.7.2. Toxicity testing
            11.7.3. Regenerative Medicine
            11.7.4. Others
     11.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            11.9.1. Academic & Research Institutes
            11.9.2. Biotechnology companies
            11.9.3. Others
     11.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     11.11. Drivers and Restraints: Impact Analysis
     11.12. Market Attractiveness Analysis
            11.12.1. By Country
            11.12.2. By Cell Type
            11.12.3. By Application
            11.12.4. By End User
     11.13. Key Market Participants – Intensity Mapping
     11.14. Drivers and Restraints – Impact Analysis
     11.15. Key Mergers & Acquisitions

12. China Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     12.1. Introduction
     12.2. Key Regulations
     12.3. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            12.3.1. Hepatocytes
            12.3.2. Fibroblasts
            12.3.3. Keratinocytes
            12.3.4. Neurons
            12.3.5. Others
     12.4. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     12.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            12.5.1. Drug Development
            12.5.2. Toxicity testing
            12.5.3. Regenerative Medicine
            12.5.4. Others
     12.6. Market Size (US$ Mn) Forecast By Application, 2018–2026
     12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            12.7.1. Academic & Research Institutes
            12.7.2. Biotechnology companies
            12.7.3. Others
     12.8. Market Size (US$ Mn) Forecast By End User, 2018–2026
     12.9. Drivers and Restraints: Impact Analysis
     12.10. Market Attractiveness Analysis
            12.10.1. By Cell Type
            12.10.2. By Application
            12.10.3. By End User
     12.11. Key Market Participants – Intensity Mapping
     12.12. Drivers and Restraints – Impact Analysis
     12.13. Key Mergers & Acquisitions

13. Middle East & Africa Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     13.1. Introduction
     13.2. Key Regulations
     13.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            13.3.1. GCC Countries
            13.3.2. South Africa
            13.3.3. Rest of MEA
     13.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
     13.5. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            13.5.1. Hepatocytes
            13.5.2. Fibroblasts
            13.5.3. Keratinocytes
            13.5.4. Neurons
            13.5.5. Others
     13.6. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     13.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            13.7.1. Drug Development
            13.7.2. Toxicity testing
            13.7.3. Regenerative Medicine
            13.7.4. Others
     13.8. Market Size (US$ Mn) Forecast By Application, 2018–2026
     13.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            13.9.1. Academic & Research Institutes
            13.9.2. Biotechnology companies
            13.9.3. Others
     13.10. Market Size (US$ Mn) Forecast By End User, 2018–2026
     13.11. Drivers and Restraints: Impact Analysis
     13.12. Market Attractiveness Analysis
            13.12.1. By Country
            13.12.2. By Cell Type
            13.12.3. By Application
            13.12.4. By End User
     13.13. Key Market Participants – Intensity Mapping
     13.14. Drivers and Restraints – Impact Analysis
     13.15. Key Mergers & Acquisitions

14. Forecast Factors: Relevance and Impact

15. Forecast Assumptions

16. Market Structure Analysis
     16.1. Market Structure by Tier of Companies
     16.2. Market Share Analysis (2016) for Top Players, By Region

17. Competition Analysis
     17.1. Competition Dashboard
     17.2. Competition Benchmarking
     17.3. Company Deep Dive
            17.3.1. Thermo Fisher Scientific Inc.
                     17.3.1.1. Overview
                     17.3.1.2. Product and Application Portfolio
                     17.3.1.3. Production Footprint
                     17.3.1.4. Sales Footprint
                     17.3.1.5. Channel Footprint
                     17.3.1.6. Strategy
                                17.3.1.6.1. Marketing Strategy
                                17.3.1.6.2. Product Strategy
                                17.3.1.6.3. Channel Strategy
            17.3.2. FUJIFILM Holdings Corporation (Cellular Dynamics)
                     17.3.2.1. Overview
                     17.3.2.2. Product and Application Portfolio
                     17.3.2.3. Production Footprint
                     17.3.2.4. Sales Footprint
                     17.3.2.5. Channel Footprint
                     17.3.2.6. Strategy
                                17.3.2.6.1. Marketing Strategy
                                17.3.2.6.2. Product Strategy
                                17.3.2.6.3. Channel Strategy
            17.3.3. Horizon Discovery Group plc.
                     17.3.3.1. Overview
                     17.3.3.2. Product and Application Portfolio
                     17.3.3.3. Production Footprint
                     17.3.3.4. Sales Footprint
                     17.3.3.5. Channel Footprint
                     17.3.3.6. Strategy
                                17.3.3.6.1. Marketing Strategy
                                17.3.3.6.2. Product Strategy
                                17.3.3.6.3. Channel Strategy
            17.3.4. Takara Bio Inc.
                     17.3.4.1. Overview
                     17.3.4.2. Product and Application Portfolio
                     17.3.4.3. Production Footprint
                     17.3.4.4. Sales Footprint
                     17.3.4.5. Channel Footprint
                     17.3.4.6. Strategy
                                17.3.4.6.1. Marketing Strategy
                                17.3.4.6.2. Product Strategy
                                17.3.4.6.3. Channel Strategy
            17.3.5. Cell Applications, Inc.
                     17.3.5.1. Overview
                     17.3.5.2. Product and Application Portfolio
                     17.3.5.3. Production Footprint
                     17.3.5.4. Sales Footprint
                     17.3.5.5. Channel Footprint
                     17.3.5.6. Strategy
                                17.3.5.6.1. Marketing Strategy
                                17.3.5.6.2. Product Strategy
                                17.3.5.6.3. Channel Strategy
            17.3.6. Lonza Group Ltd.
                     17.3.6.1. Overview
                     17.3.6.2. Product and Application Portfolio
                     17.3.6.3. Production Footprint
                     17.3.6.4. Sales Footprint
                     17.3.6.5. Channel Footprint
                     17.3.6.6. Strategy
                                17.3.6.6.1. Marketing Strategy
                                17.3.6.6.2. Product Strategy
                                17.3.6.6.3. Channel Strategy

18. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     18.1. Introduction/Key Findings
     18.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
     18.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
            18.3.1. North America
            18.3.2. Latin America
            18.3.3. Europe
            18.3.4. Asia Pacific
            18.3.5. Middle East & Africa
            18.3.6. China
     18.4. Market Attractiveness Analysis By Region

19. Global Induced Pluripotent Stem Cells Analysis 2013–2017 and Forecast 2018–2026, By Cell Type
     19.1. Introduction/Key Findings
     19.2. Historical Market Size (US$ Mn) Trend Analysis By Cell Type, 2013–2017
            19.2.1. Hepatocytes
            19.2.2. Fibroblasts
            19.2.3. Keratinocytes
            19.2.4. Neurons
            19.2.5. Others
     19.3. Market Size (US$ Mn) Forecast By Cell Type, 2018–2026
     19.4. Market Attractiveness Analysis By Cell Type

20. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By Application
     20.1. Introduction/Key Findings
     20.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017
            20.2.1. Drug Development
            20.2.2. Toxicity testing
            20.2.3. Regenerative Medicine
            20.2.4. Others
     20.3. Market Size (US$ Mn) Forecast By Application, 2018–2026
     20.4. Market Attractiveness Analysis By Application

21. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026, By End User
     21.1. Introduction/Key Findings
     21.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            21.2.1. Academic & Research Institutes
            21.2.2. Biotechnology companies
            21.2.3. Others
     21.3. Market Size (US$ Mn) Forecast By End User, 2018–2026
     21.4. Market Attractiveness Analysis By End User

22. Global Induced Pluripotent Stem Cells Market Analysis 2013–2017 and Forecast 2018–2026
     22.1. Market Value Share Analysis By All Segment
     22.2. Y-o-Y Growth Analysis By All Segment
     22.3. Absolute $ Opportunity

23. Assumptions and Acronyms

24. Research Methodology

List of Tables

List of Tables

Table 01: Comparison of Stem Cell Types

Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 03: Expenditure on Health, (% of GDP), by Country, 2016 - 2021

Table 04: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 05: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 06: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 07: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 08: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 09: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 10: Induced Pluripotent Stem Cells (iPSCs) Clinical Trials

Table 11: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country

Table 12: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 13: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 15: North America Induced Pluripotent Stem Cell Market Company Intensity Map

Table 16: Economic support and stem cell research for the major countries in Latin America, (2013)

Table 17: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country

Table 18: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 19: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 20: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 21: Latin America Induced Pluripotent Stem Cell Market Company Intensity Map

Table 22: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country

Table 23: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 24: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 25: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 26: Europe Induced Pluripotent Stem Cell Market Company Intensity Map

Table 28: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country

Table 29: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 30: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 31: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 32: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Company Intensity Map

Table 33: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 34: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 35: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 36: China Induced Pluripotent Stem Cell Market Company Intensity Map

Table 37: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country

Table 38: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 39: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 40: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

Table 41: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Company Intensity Map

Table 42: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region

Table 43: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Cell Type

Table 44: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application Type

Table 45: Global Induced Pluripotent Stem Cell Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User

List of Chart

List of Figures

Figure 01: All R&D expenditure, by Source of Fund, 2011

Figure 02: R&D expenditure in Life Science, by R&D Field, 2011

Figure 03: Leading cause of Death, 2014

Figure 04: Global Stem Cell Market Overview (2016E)

Figure 05: Main Obstacles in Stem Cell Research

Figure 06: Number of Companies (estimated) Offering iPSC Research products, by Year

Figure 07: Global Healthcare Expenditure in US$ Tn (2013–2020)

Figure 08: The Number of Estimated Active Researchers in Stem Cell Research Worldwide

Figure 09: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country

Figure 10: North America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User

Figure 11: iPSC Specific U.S. Patents, by patent type, 2015

Figure 12: National contribution to iPSC invention, by country, 2014

Figure 13: Total number of patents for iPSC technologies (Est.)

Figure 14: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 15: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 16: North America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026

Figure 17: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 18: U.S. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 19: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 20: Canada Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 21: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 22: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 23: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 24: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 25: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 26: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 27: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 28: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 29: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 30: North America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 31: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 32: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 33: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 34: North America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country

Figure 35: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Country

Figure 36: Latin America Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User

Figure 37: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 38: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 39: Latin America Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026

Figure 40: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 41: Brazil Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 42: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 43: Mexico Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 44: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 45: Argentina Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 46: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 47: Rest of Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 48: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 49: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 50: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 51: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 52: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 53: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 54: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 55: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 56: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 57: Latin America Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 58: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 59: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 60: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 61: Latin America Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country

Figure 62: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Country

Figure 63: Europe Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User

Figure 64: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 65: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 66: Europe Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026

Figure 67: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 68: Germany Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 69: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 70: U.K. Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 71: France Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 72: France Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 73: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 74: Italy Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 75: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 76: Spain Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 77: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 78: Russia Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 79: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Country

Figure 80: Rest of Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 81: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 82: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 83: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 84: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 85: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 86: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 87: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 88: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 89: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 90: Europe Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 91: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 92: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 93: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 94: Europe Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country

Figure 95: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country

Figure 96: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User

Figure 97: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 98: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 99: APEC Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026

Figure 100: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 101: Japan Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 102: India Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 103: India Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 104: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 105: Australia and New Zealand Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 106: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 107: Rest of APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 108: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 109: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 110: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 111: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 112: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 113: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 114: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 115: APEC Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 116: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 117: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 118: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 119: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 120: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 121: Asia Pacific excluding China (APEC) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country

Figure 123: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 124: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 125: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 126: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 127: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 128: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 129: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 130: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 131: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 132: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 133: China Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 134: China Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 135: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 136: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 137: China Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 138: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Country

Figure 139: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Value Share (2017A), By Cell Type, Application and End User

Figure 140: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013-2017

Figure 141: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026

Figure 142: MEA Induced Pluripotent Stem Cell Market Y-o-Y growth (%) Comparison, By Country, 2018-2026

Figure 143: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 144: GCC Countries Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 145: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 146: South Africa Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 147: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017

Figure 148: Rest of MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 149: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Hepatocytes

Figure 150: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Hepatocytes

Figure 151: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Fibroblasts

Figure 152: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Fibroblasts

Figure 153: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Keratinocytes

Figure 154: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Keratinocytes

Figure 155: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Neurons

Figure 156: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Neurons

Figure 157: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) Analysis, 2013–2017, By Others

Figure 158: MEA Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Others

Figure 159: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 160: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 161: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 162: Middle East and Africa (MEA) Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Country

Figure 163: Revenue Contribution by Tier Type (2016)

Figure 164: Global Induced Pluripotent Stem Cell Market Share (%) Analysis

Figure 165: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Region

Figure 166: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Cell Type

Figure 167: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By Application Type

Figure 168: Global Induced Pluripotent Stem Cell Market Attractiveness Analysis, By End User

Figure 169: Global Induced Pluripotent Stem Cell Market Size and Y-o-Y, 2013 - 2017

Figure 170: Global Induced Pluripotent Stem Cell Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026

Figure 171: Global Induced Pluripotent Stem Cell Market Absolute $ Opportunity, 2017–2026

Description

Overview of the iPS Cell Market with Reference to the Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

• Current expenditure on health, % of gross domestic product
• Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
• Annual growth rate of current expenditure on health, per capita, in real terms
• Out-of-pocket expenditure, % of current expenditure on health
• Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
• Physicians, Density per 1000 population (head counts)
• Nurses, Density per 1000 population (head counts)
• Total hospital beds, per 1000 population
• Curative (acute) care beds, per 1000 population
• Medical technology, Magnetic Resonance Imaging units, total, per million population
• Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

PMR utilizes a triangulation methodology that is primarily based on overall expenditure on life science research and R&D funding and capital equipment installed base to obtain precise market estimations and insights on life science and biotechnology associated products, technologies, applications and services. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country-specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users is tracked at a granular level to obtain the most accurate information. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project year-on-year growth rates. These Y-o-Y growth projections are checked and aligned as per associated industry/product lifecycles and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse annual reports_bk_01_01_2020 of various companies, investor presentations, SEC filings, 10k reports_bk_01_01_2020 and earning call transcripts operating in the market to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at tier-level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as overall life science research expenditure, R&D funding, industry based demand driving factors impacting the market and its forecast trends apart from other macroeconomic factors.

Standard Report Structure

• Executive Summary
• Market Definition
• Macro-economic analysis
• Parent Market Analysis
• Market Overview
• Forecast Factors
• Segmental Analysis and Forecast
• Regional Analysis
• Competition Analysis